IBM Watson Health to aid in matching cancer patients to clinical trials – MassDevice

IBM's (NYSE:IBM) famed Watson artificial intelligence platform will be put to use to help match cancer patients with clinical trials. The Armonk, N.Y.-based technology giant said Froedtert & the Medical College of Wisconsin Network will adopt the Watson technology for this purpose in a project set to begin this fall. Froedtert/MCW Cancer Network are among the 1st cancer programs nationally to use the technology, according to IBM. Doctors typically try to match patients to genetically ideal clinical trials that are also the most relevant in the development spectrum. This can be a long process on multiple levels, involving reviews by clinical coordinators who manually sort through patient records and conditions.